You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The psychiatric side-effects of rimonabant
|
|---|---|
| Published in |
Revista Brasileira de Psiquiatria, June 2009
|
| DOI | 10.1590/s1516-44462009000200012 |
| Pubmed ID | |
| Authors |
Fabrício A. Moreira, José Alexandre S. Crippa |
| Abstract |
Experimental evidence has suggested that drugs that enhance cannabinoid type-1 (CB1) receptor activity may induce anxiolytic and antidepressant effects, whilst the opposite has been reported with antagonists. Thus, the objective of the present review is to discuss the potential psychiatric side-effects of CB1 receptor antagonists, such as rimonabant, which has been recently marketed in several countries for the treatment of smoking cessation, obesity and associated metabolic disorders. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 60% |
| Portugal | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 265 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Netherlands | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 261 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 60 | 23% |
| Student > Ph. D. Student | 39 | 15% |
| Student > Master | 33 | 12% |
| Researcher | 30 | 11% |
| Student > Postgraduate | 16 | 6% |
| Other | 41 | 15% |
| Unknown | 46 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 18% |
| Agricultural and Biological Sciences | 29 | 11% |
| Neuroscience | 28 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 28 | 11% |
| Biochemistry, Genetics and Molecular Biology | 24 | 9% |
| Other | 47 | 18% |
| Unknown | 61 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 64. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 June 2024.
All research outputs
#691,303
of 26,178,431 outputs
Outputs from Revista Brasileira de Psiquiatria
#15
of 916 outputs
Outputs of similar age
#1,687
of 126,019 outputs
Outputs of similar age from Revista Brasileira de Psiquiatria
#1
of 8 outputs
Altmetric has tracked 26,178,431 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 916 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,019 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them